{
  "id": 14261042,
  "title": "No Effect of GLP-1s on Anti-VEGF Injection Frequency for Diabetic Macular Edema",
  "url": "https://urgent.news/2026/10/13/no-effect-of-glp-1s-on-anti-vegf-injection-frequency-for-diabetic",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-13T17:49:09.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/aao/123385"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- NEW ORLEANS -- GLP-1 receptor agonists did not significantly affect anti-VEGF treatment frequency in patients with diabetic macular edema (DME), a large retrospective cohort study showed. Over 24 months of follow-up, \"no sustained...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}